ArticleHealthcare (Basel, Switzerland)2025
Association Between Common Systemic Medications and the Presence and Severity of Furcation Involvement: A Cross-Sectional Study.
Article in Healthcare (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesWhile furcation involvement is a known predictor for tooth loss, the role of systemic medications is understudied. This study aimed to investigate the association between common systemic medications and both the presence and severity of furcation involvement in a large patient cohort.
methodsThis retrospective cross-sectional study analyzed electronic health records from 15,881 patients within the BigMouth Dental Data Repository. The association between demographics, medication use (ACE inhibitors, statins, anti-coagulants, antidepressants, bisphosphonates, proton pump inhibitors), and the presence of furcation involvement was assessed using Chi-Square tests and multivariate logistic regression. The statistically significant relationship between medications and furcation severity (Grades 1-4) was analyzed using multinomial logistic regression.
resultsBeing male (OR: 1.34) and of non-Hispanic ethnicity (OR: 1.36) were significant demographic predictors for furcation involvement. After adjusting for demographics, use of ACE inhibitors (OR: 1.40), anti-coagulants (OR: 1.19), and statins (OR: 1.14) were significantly associated with higher odds of furcation involvement. Specifically, Lisinopril (OR: 1.48), Enalapril (OR: 1.83), and Atorvastatin (OR: 1.27) were significant predictors. Furthermore, patients taking Lisinopril, Aspirin, Atorvastatin, or Simvastatin had approximately 1.5 times the odds of having Grade 3 involvement compared to Grade 1 (
conclusionsThe use of certain systemic medications, particularly for cardiovascular conditions, is independently associated with both a higher likelihood and increased severity of furcation involvement, highlighting the critical need for dental professionals to consider a patient's medication profile as an integral part of periodontal risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.